About me

Bridging Biophysics and Disease Biology to Accelerate Drug Discovery.

Biotech scientist with 6+ years of industry experience in neurodegeneration therapeutics, currently pursuing a Ph.D. in Biomedical Sciences at UT Southwestern Medical Center.

I am is a translational scientist driven by the challenge of uncovering the science that drives complex diseases and developing innovative therapies to treat them. Before joining UT Southwestern Medical Center to deepen my focus on disease biology, she spent over six years in the biotech industry across Silicon Therapeutics, Roivant Sciences, and Denali Therapeutics.

During my time in the industry, I specialized in defining the mechanisms of action, binding partners, and kinetics of therapeutic targets. I have a proven track record of producing challenging target proteins, optimizing complex assays, and integrating automation platforms to significantly boost throughput and reproducibility.

Core Expertise:

• Biophysics & Biochemistry: Surface Plasmon Resonance (SPR), Homogeneous Time-Resolved Fluorescence (HTRF), FACS, MSD, and ELISA.
• Protein Engineering: Recombinant protein expression and purification using AKTA-FPLC across mammalian, bacterial, and insect expression systems.
• Assay Development & Automation: Luminescence-based functional assays, high-content imaging (Opera Phenix), and integrating Bravo and DD Lynx automation platforms.
• Target Enablement: Supporting structural enablement through NMR, HDX, and crystallography studies.

Current Research & Academic Pursuits: (This is where she can add a 2-3 sentence summary of her specific focus within the Dauer Lab, explaining how she is applying her industry background to her current Ph.D. projects.)